Techno Medica Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	1,525	1,319	1,860	1,665	1,851
Depreciation & Amortization	92	99	112	108	120
Loss (Gain) From Sale of Assets	-	-	9	2	-
Other Operating Activities	-260	-572	-493	-642	-628
Change in Accounts Receivable	-478	392	-723	77	-46
Change in Inventory	325	-452	-289	-636	416
Change in Accounts Payable	-276	160	-84	217	147
Change in Other Net Operating Assets	172	31	750	96	202
Operating Cash Flow	1,100	977	1,142	887	2,062
Operating Cash Flow Growth	12.59%	-14.45%	28.75%	-56.98%	149.94%
Capital Expenditures	-35	-25	-37	-133	-66
Sale (Purchase) of Intangibles	-6	-6	-64	-5	-14
Investment in Securities	-	-	-	-	2,568
Other Investing Activities	2	-1	1	-17	1
Investing Cash Flow	-39	-32	-100	-155	2,489
Repurchase of Common Stock	-674	-	-3,697	-	-164
Common Dividends Paid	-471	-470	-508	-505	-434
Financing Cash Flow	-1,145	-470	-4,205	-505	-598
Miscellaneous Cash Flow Adjustments	-1	-	-	-1	-
Net Cash Flow	-85	475	-3,163	226	3,953
Free Cash Flow	1,065	952	1,105	754	1,996
Free Cash Flow Growth	11.87%	-13.85%	46.55%	-62.22%	151.07%
Free Cash Flow Margin	9.48%	9.61%	10.75%	8.05%	20.58%
Free Cash Flow Per Share	154.41	137.48	141.76	89.34	234.98
Cash Income Tax Paid	259	574	495	644	630
Levered Free Cash Flow	798.5	674.5	772	572.63	1,817
Unlevered Free Cash Flow	798.5	674.5	772	572.63	1,817
Change in Working Capital	-257	131	-346	-246	719